{
    "code": "02017852",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02017852",
    "time": "2020-02-25 11:44:37",
    "許可證字號": "衛署藥輸字第017852號",
    "註銷狀態": "已註銷",
    "註銷日期": "105\/03\/16",
    "註銷理由": "自請註銷",
    "有效日期": "108\/12\/20",
    "發證日期": "103\/06\/28",
    "許可證種類": "製　劑",
    "舊證字號": "02017647",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00201785207",
    "中文品名": "欽納特錠２５０公絲",
    "英文品名": "ZINNAT TABLET 250MG",
    "適應症": "對廣範圍的革蘭氏陽性及革蘭氏陰性細菌有效，適用於治療對ＣＥＦＵＲＯＸＩＭＥ敏感的細菌所引起的上、下呼吸道、生殖泌尿道、皮膚、軟組織、淋病及早期萊姆病(Lyme disease)並有移行性紅斑等感染症",
    "劑型": "116膜衣錠",
    "包裝": "4-1000粒鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "06須由醫師處方使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "02輸　入",
        "申請商名稱": "0901801100  荷商葛蘭素史克藥廠股份有限公司台灣分公司",
        "申請商地址": "台北市中正區忠孝西路一段66號23-24樓",
        "主製造廠": ""
    },
    "CCC號列": "30042000319 人用醫藥製劑，含頭孢子菌類抗生素者Medicaments, containing cephalosporins, for human use",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0812391120",
            "成分名稱": "CEFUROXIME (AXETIL)",
            "含量描述": "(300.72MG)",
            "含量": "250.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "白色",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "長圓柱形",
        "標記一": "Glaxo",
        "標記二": "250"
    },
    "藥物辨識外觀圖片": [
        {
            "title": "02017852.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02017852&Seq=422&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "020178520009.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02017852&Seq=009&Type=9"
        },
        {
            "title": "020178520003.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02017852&Seq=003&Type=8"
        }
    ]
}